Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $8.33 billion. The enterprise value is $12.09 billion.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 60.66 million shares outstanding. The number of shares has decreased by -12.92% in one year.
| Current Share Class | 60.66M |
| Shares Outstanding | 60.66M |
| Shares Change (YoY) | -12.92% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 3.08% |
| Owned by Institutions (%) | 103.60% |
| Float | 58.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.40 |
| PS Ratio | 2.05 |
| Forward PS | 1.88 |
| PB Ratio | 2.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.58 |
| P/OCF Ratio | 6.33 |
| PEG Ratio | 0.54 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.57, with an EV/FCF ratio of 9.56.
| EV / Earnings | n/a |
| EV / Sales | 2.96 |
| EV / EBITDA | 7.57 |
| EV / EBIT | 13.06 |
| EV / FCF | 9.56 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 1.47.
| Current Ratio | 1.62 |
| Quick Ratio | 1.15 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 4.29 |
| Interest Coverage | 2.93 |
Financial Efficiency
Return on equity (ROE) is -10.84% and return on invested capital (ROIC) is 6.19%.
| Return on Equity (ROE) | -10.84% |
| Return on Assets (ROA) | 5.19% |
| Return on Invested Capital (ROIC) | 6.19% |
| Return on Capital Employed (ROCE) | 10.43% |
| Revenue Per Employee | $1.46M |
| Profits Per Employee | -$144,586 |
| Employee Count | 2,800 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 0.61 |
Taxes
| Income Tax | -107.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.59% in the last 52 weeks. The beta is 0.28, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +24.59% |
| 50-Day Moving Average | 124.33 |
| 200-Day Moving Average | 120.19 |
| Relative Strength Index (RSI) | 63.28 |
| Average Volume (20 Days) | 758,467 |
Short Selling Information
The latest short interest is 5.30 million, so 8.74% of the outstanding shares have been sold short.
| Short Interest | 5.30M |
| Short Previous Month | 5.71M |
| Short % of Shares Out | 8.74% |
| Short % of Float | 9.04% |
| Short Ratio (days to cover) | 7.53 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.09 billion and -$404.84 million in losses. Loss per share was -$6.63.
| Revenue | 4.09B |
| Gross Profit | 3.77B |
| Operating Income | 925.88M |
| Pretax Income | -512.27M |
| Net Income | -404.84M |
| EBITDA | 1.60B |
| EBIT | 925.88M |
| Loss Per Share | -$6.63 |
Full Income StatementBalance Sheet
The company has $1.67 billion in cash and $5.43 billion in debt, giving a net cash position of -$3.76 billion or -$62.04 per share.
| Cash & Cash Equivalents | 1.67B |
| Total Debt | 5.43B |
| Net Cash | -3.76B |
| Net Cash Per Share | -$62.04 |
| Equity (Book Value) | 3.71B |
| Book Value Per Share | 61.12 |
| Working Capital | 1.28B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.32 billion and capital expenditures -$50.92 million, giving a free cash flow of $1.27 billion.
| Operating Cash Flow | 1.32B |
| Capital Expenditures | -50.92M |
| Free Cash Flow | 1.27B |
| FCF Per Share | $20.86 |
Full Cash Flow StatementMargins
Gross margin is 92.14%, with operating and profit margins of 22.66% and -9.91%.
| Gross Margin | 92.14% |
| Operating Margin | 22.66% |
| Pretax Margin | -12.54% |
| Profit Margin | -9.91% |
| EBITDA Margin | 39.11% |
| EBIT Margin | 22.66% |
| FCF Margin | 30.96% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 12.92% |
| Shareholder Yield | 12.92% |
| Earnings Yield | -4.86% |
| FCF Yield | 15.19% |
Dividend DetailsAnalyst Forecast
The average price target for JAZZ is $179.21, which is 30.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $179.21 |
| Price Target Difference | 30.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 6.61% |
| EPS Growth Forecast (5Y) | 27.86% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.41 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.41 |
| Piotroski F-Score | 5 |
